AAO 2026 – Clinical Trial Updates Part III
Emily H. Jung, MD Duke Eye Center, Durham, NC GLOW2 Study: Phase 3 Study of Tarcocimab for Diabetic Retinopathy Margaret A. Chang, MD (Retinal Consultants Medical Group, Sacramento, CA) Dr.…
Emily H. Jung, MD Duke Eye Center, Durham, NC GLOW2 Study: Phase 3 Study of Tarcocimab for Diabetic Retinopathy Margaret A. Chang, MD (Retinal Consultants Medical Group, Sacramento, CA) Dr.…
Jovany Franco, MD Kellogg Eye Center, University of Michigan, Ann Harbor, MI Subretinal Gene Therapy Laru-zova for X-linked Retinitis Pigmentosa (XLRP): Pivotal VISTA Trial First-time Results Robert Sisk, MD The…
Trisha Ortiz Wills Eye Hospital Thomas Jefferson University Hospitals Drs. Jordan D. Deaner, James P. Dunn, Sara E. Lally, and Carol L. Shields moderated the 6th session of MACULA 2026…
Melissa Yuan, MD Ophthalmology Resident Massachusetts Eye and Ear Infirmary The 2024 conference finished strong with the medical and surgical case conferences. The medical case conference session was moderated by…
Jennifer Hu, MD Mass Eye and Ear, Boston, MA Sessions 3 and 6 of the trainee cases were full of interesting presentations from our residents and fellows. Dr. Erin Flynn…
Melissa Yuan, MD Mass Eye and Ear Boston, MA The Saturday session kicked off with Dr. Andre Witkin presenting a talk on behalf of the ReST committee entitled, “Update on…
Asad F. Durrani, MD Wills Eye Hospital Philadelphia, PA During this session of Atlantic Coast Retina Club 2023, faculty presented their most interesting and challenging cases of the past year.…
Saagar Pandit, MD Wills Eye Hospital Philadelphia, PA Dr. Miguel Vasquez Membrillo presented on an interesting case of a 72 year old white female referred to the ocular oncology service…